pis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AIRE holy cow Batman - geez, ipo that keeps dropping after huge first day
SGHT Item?7.01
Regulation FD Disclosure
Sight Sciences, Inc. (the “Company”) is evaluating its guidance for full year 2023 due to the uncertain impact of reimbursement coverage for its Surgical Glaucoma segment discussed below. The Company plans to discuss any updates to its guidance on its upcoming earnings conference call currently scheduled to be held on November 7, 2023.*
Sorry to hear - hope you feel better
SGHT down 50% don't see anything yet
SONN down 36% offering priced at $1.60
NUZE down 40% offering priced at 3
EVLO down 55% Evelo Biosciences said it is reviewing strategic alternatives after its Phase 2 clinical trial of EDP2939 for the treatment of moderate psoriasis failed to meet its primary endpoint.
MANU down 11% Qatari banker Sheikh Jassim is withdrawing his bid to buy Manchester United
BIOC down 59% After considering strategic alternatives, Biocept, Inc., a Delaware corporation (the “Company”), filed a voluntary petition for relief (the “Petition”) under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. (the “Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) on October 13, 2023.
OMER down 46% Omeros said it is discontinuing its late-stage clinical trial evaluating its narsoplimab drug for the treatment of immunoglobulin A nephropathy after interim data from the trial failed to meet its primary endpoint.
ALDX down 73% The FDA stated that "t does not appear that you have data to support the clinical relevance of the ocular signs to support your dry eye indication."
OM down 50% reported lower-than-expected preliminary third-quarter revenue and warned of lower capital spending in the fourth quarter.
PHIO down 41% after huge run yesterday when they reported favorable data from two preclinical studies
HOFV down 29% offering priced at 3.75
SILK down 50% lowered its full-year revenue outlook
I flipped it for a buck gain. - edit actually for a 1.32 gain - should have held it longer I would have been up four bucks.
AKRO down 68% the company released an update on its lead product candidate, a treatment for nonalcoholic steatohepatitis, a form of fatty liver disease.
To add insult to injury SEEL has an offering the day after they huge drop. Priced at .30. Down another 34% today.
Ok, I finally dipped in and got some ARM - hope I want them.
SEEL down 76% - too small sample size means the study did not meet its primary end point
Yes, I have been watching it.
Sold that one way too early at 2.88 - nice bounce.
SPRY down 59% after FDA responce
Hi Shawn! So it ends up that they weren't able to migrate any of my positions that had multiple lots into TOS. They told me that anything I buy after the migration will show lots but anything before will not. They told me to go to the website to see my lots. I told them that this isn't 1999 and I don't want to be trading off a website. That's fine for someone who is long term and buys and sells every now and then. For someone who does multiple trades everyday you can't be trading off a website - you need a trading platform. They informed me that this problem will eventually get fixed where my prior history will show lots, but they could not give me a window of when. So I asked them if they could switch me back to StreetSmart and hopefully by the time they phase out that platform they fix that problem with TOS. They agreed and this morning I got my StreetSmart with all my correct positions back.
I haven't tried to see if TOS still works since they already migrated me that may be a chance.
I am totally with you on TOS. Way too many bells and whistles on that platform that I will never use. I still like Etrade Pro the best in terms of what it has to offer and the appearance. TOS is hard on the eyes and you can't change the font to bold where you can do that on Pro. I just hope Etrade doesn't have any ideas about phasing out Pro with a different platform.
UPH down 57% on judgement order: summary judgment in favor of Needham looks like a bk - saw this on twitter:
https://bkdata.com/business-bankruptcies/delaware-delaware/09-19-2023/uphealth-holdings-11476
I'm sure it also takes a bit of getting used to it too. The more I use it the easier it will be to remember where it is.
Yes, I think that is right. Like Asian or Hebrew speaking people who read right to left will automatically start on the right naturally.
I like the new "mail envelope" and "profile icon." I just think I naturally begin looking at a page on the left side first. I know the Ihub emblem is there but I think it is easier to see if it were on the left side:
Summary: Web users spend 80% of their time viewing the left half of the page and 20% viewing the right half. Adhering to design conventions will help maximize users’ efficiency and company profits.
https://www.nngroup.com/articles/horizontal-attention-leans-left/
My husband sold our Fusion. Good riddance. I hated that car.
So my buy order for 48 yesterday never filled - lmao!
Dumb arses at SinkorSwim never informed me that once they give me access to the platform that StreetSmartEdge is no longer available to trade off of! So I have this new platform that I have no clue how it works, the account info hasn't been transferred correctly yet - my lots aren't showing up and they don't have me flagged as a pattern day trader on it yet.
I will have to use the website - which is something I never use and am not too familiar with either!
Help! I'm definitely sinking and not swimming - it's rip current season! lol
Which one do you use? The web based one or the desktop platform. I have the desktop right now. From what I understand that one is more involved. I might try the web based one.
One other point. They told me that they will be phasing out StreetSmart so I guess SinkorSwim will be the only trading platform to use with Schwab!
I first had to sign up for it and have to wait for them to activate it.
We're excited to let you know that as a valued Schwab client, you now have exclusive early access to the award-winning suite of thinkorswim® trading platforms. Read on to learn how to use your access to check out these platforms and get your account(s) set up to trade on them.
Ok that's in line with what they were predicting around 51.
Perfect. Thanks
Is it pricing today and trading tomorrow?
ARM is supposed to IPO today
Arm Holdings plc architects, develops, and licenses central processing unit products and related technologies for semiconductor companies and original equipment manufacturers rely on to develop products. It offers microprocessors, systems intellectual property (IPs), graphics processing units, physical IP and associated systems IPs, software, tools, and other related services. Its products are used in various markets, such as automotive, computing infrastructure, consumer technologies, and Internet of things. The company operates in the United States, the People's Republic of China, Taiwan, South Korea, and internationally. The company was founded in 1990 and is headquartered in Cambridge, the United Kingdom. Arm Holdings plc operates as a subsidiary of Kronos II LLC.
https://finance.yahoo.com/quote/ARM/profile?p=ARM
Same one with the termnination provision:
Ordinary Share, to purchase up to 8,849,558 Ordinary Shares, in a registered direct offering to certain institutional investors, pursuant to the Securities Purchase Agreement. The Securities Purchase Agreement was terminated by the Company and the Investors on September 11, 2023, pursuant to Termination Agreements between the Company and each of the Investors (the “Termination Agreements”), except for the sale of 351,433 pre-settlement Ordinary Shares sold to one of the Investors at a price of $1.13 per share, for a total purchase price of $397,119
I think it was immediately available if you were an Ameritrade customer. I was a new Schwab customer so I didn't have immediate access. I know nothing about OTC share limitations since I do not trade otc stocks anymore.
EZGO filing: On September 11, 2023, the Company entered into termination agreements for the termination of the sale of 8,849,558 Ordinary Shares and accompanying Warrants, except as to 351,433 Ordinary Shares to one institutional investor that are being sold in this offering.
https://www.otcmarkets.com/filing/html?id=16923521&guid=MOg-kqt7kD7fJth